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Background
Biochemical markers of bone turnover provide a means of
evaluating skeletal dynamics that complements static
measurements of bone mineral density (BMD). This study
was designed to examine biochemical markers of bone
metabolism in myelomeningocele (MMC) patients.
Patients and methods
Eighty patients with myelomeningocele were randomly
chosen from a roster of >500 patients with myelomenin-
gocele followed at a multidisciplinary spina bifida unit in
a public tertiary university hospital. Patients with known
metabolic acidosis, renal insufficiency, or other metabolic
bone disease (i.e., hyperparathyroidism) were excluded.
The methods used in the study were clinical interview and
examination, measurement of total-body bone mineral
density (BMD) with subregional values and estimation of
biochemical markers of bone turnover (formation: osteo-
calcin, bone specific alkaline phosphatase (BSAP); resorp-
tion: urinary deoxypyridinolines, type I collagen cross
linked N-telopeptide (NTx)) and the main parameters of
calcium phosphate metabolism in blood and/or urine. To
study relationships among the variables, the Chi-squared,
ANOVA and lineal regression tests were applied.
Results
The formation bone markers were into the normal values
while the resorption bone markers were higher than nor-
mal values. The bivariate analysis showed statistically sig-
nificant relationships between bone mineral markers and
age, body mass index, hip flexion contractures, intake of
calcium, and abnormalities in menstrual period. Bone
resorption markers were related with pelvis BMD. Bone
formation markers were related with trunk, spine and
total body BMD. PTH was related with trunk and total
body BMD. The multivariate approach demonstrated that
BSAP levels were determinate by body mass index (p =
0.002), urinary deoxypyridinolines (p = 0.002) and neu-
rological level (p = 0.013). Osteocalcine levels were deter-
minate by calcium intake (p = 0.001) and sex (p = 0.008).
Urinary deoxypyridolines levels were determinate by urea
(p = 0.001) and hip flexion contractures (p = 0.009).
Finally, NTx levels were determinate by calcium intake (p
= 0.001).
Conclusion
Biochemical markers of bone mineral metabolism in
myelomeningocele could be a good tool to evaluate the
bone metabolism although it is necessary have a pro-
longed follow-up in order to conclude their real value in
the current practice.
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